Pharmacokinetic Model-Driven Remifentanil Administration in the Morbidly Obese: The `Critical Weight' and the `Fictitious Height', a Possible Solution to an Unsolved Problem?

Author： Colla L. La  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.48, Iss.6, 2009-06, pp. : 397-398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medication Non-Adherence in the Elderly: How Big is the Problem?

By Carmel M. Hughes  

Drugs & Aging, Vol. 21, Iss. 12, 2004-01 ,pp. : 793-811

Adis International

Access to resources Recommend Favorite

Predictive Performance of the `Minto' Remifentanil Pharmacokinetic Parameter Set in Morbidly Obese Patients Ensuing from a New Method for Calculating Lean Body Mass

By >  

Clinical Pharmacokinetics, Vol. 49, Iss. 2, 2010-02 ,pp. : 131-139

Adis International

Access to resources Recommend Favorite

Is Covert Medication in Norwegian Nursing Homes Still a Problem?: A Cross-Sectional Study

By Kirkevold Øyvind   Engedal Knut  

Drugs & Aging, Vol. 26, Iss. 4, 2009-05 ,pp. : 333-344

Adis International

Access to resources Recommend Favorite

Remifentanil cost saving vs fentanyl in CABG surgery?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 388, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

The Management of Hypertension in the Overweight and Obese Patient: Is Weight Reduction Sufficient?

By Jacob S.  

Drugs, Vol. 64, Iss. 11, 2004-01 ,pp. : 1263-1263

Adis International

Access to resources Recommend Favorite